Results 51 to 60 of about 2,278,950 (331)

A Quality Improvement Initiative to Standardize Pneumocystis jirovecii Pneumonia Prophylaxis in Pediatric Patients With Solid Tumors

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Pediatric patients with extracranial solid tumors (ST) receiving chemotherapy are at an increased risk for Pneumocystis jirovecii pneumonia (PJP). However, evidence guiding prophylaxis practices in this population is limited. A PJP‐related fatality at our institution highlighted inconsistent prescribing approaches and concerns about
Kriti Kumar   +8 more
wiley   +1 more source

Sickle Cell Disease Is an Inherent Risk for Asthma in a Sibling Comparison Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Sickle cell disease (SCD) and asthma share a complex relationship. Although estimates vary, asthma prevalence in children with SCD is believed to be comparable to or higher than the general population. Determining whether SCD confers an increased risk for asthma remains challenging due to overlapping symptoms and the ...
Suhei C. Zuleta De Bernardis   +9 more
wiley   +1 more source

Earth Science and Biodiversity Journals can Improve Support for Data Sharing

open access: yesData Science Journal, 2020
This study reviews research data policies and author instructions of 31 journals from the Earth sciences and from Biodiversity that are published by German learned societies or research institutions. 12 journals don’t address data sharing at all.
Andreas Hübner
doaj   +1 more source

Pazopanib Combined With Vincristine and Irinotecan in Relapsed Wilms Tumor: Encouraging Outcomes in a Heavily Pretreated Pediatric Cohort

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background While Wilms tumor (WT) typically has a favorable prognosis, relapsed cases—especially those with high‐risk histology—remain therapeutically challenging after intensive frontline therapy. The combination of vincristine and irinotecan has demonstrated activity in pediatric solid tumors, and pazopanib, a multi‐targeted tyrosine kinase ...
Maria Debora De Pasquale   +6 more
wiley   +1 more source

Reusable, FAIR Humanities Data

open access: yesInternational Journal of Digital Curation, 2022
While stakeholders including funding agencies and academic publishers implement more stringent data sharing policies, challenges remain for researchers in the humanities who are increasingly prompted to share their research data. This paper outlines some
Rebecca Grant
doaj   +1 more source

{iFair}: {L}earning Individually Fair Data Representations for Algorithmic Decision Making [PDF]

open access: yes, 2018
People are rated and ranked, towards algorithmic decision making in an increasing number of applications, typically based on machine learning. Research on how to incorporate fairness into such tasks has prevalently pursued the paradigm of group fairness:
Gummadi, K., Lahoti, P., Weikum, G.
core   +1 more source

How FAIR can you get? Image Retrieval as a Use Case to calculate FAIR Metrics

open access: yes, 2018
A large number of services for research data management strive to adhere to the FAIR guiding principles for scientific data management and stewardship. To evaluate these services and to indicate possible improvements, use-case-centric metrics are needed ...
Kranzlmüller, Dieter, Weber, Tobias
core   +1 more source

Nuclear surface studies with antiprotonic atom X-rays [PDF]

open access: yes, 2007
The recent and older level shifts and widths in pbar atoms are analyzed. The results are fitted by an antiproton-nucleus optical potential with two basic complex strength parameters.
A. Bohr   +8 more
core   +2 more sources

The MedSupport Multilevel Intervention to Enhance Support for Pediatric Medication Adherence: Development and Feasibility Testing

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction We developed MedSupport, a multilevel medication adherence intervention designed to address root barriers to medication adherence. This study sought to explore the feasibility and acceptability of the MedSupport intervention strategies to support a future full‐scale randomized controlled trial.
Elizabeth G. Bouchard   +8 more
wiley   +1 more source

Licensing FAIR Data for Reuse [PDF]

open access: yesData Intelligence, 2020
The last letter of the FAIR acronym stands for Reusability. Data and metadata should be made available with a clear and accessible usage license. But, what are the choices? How can researchers share data and allow reusability? Are all the licenses available for sharing content suitable for data?
Labastida, Ignasi, Margoni, Thomas
openaire   +3 more sources

Home - About - Disclaimer - Privacy